CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | 146.55%1.67B | 92.84%1.48B | 55.55%978.17M | 77.06%1.29B | -19.06%675.52M | -16.88%766.33M | -35.61%628.83M | 705.22%729.93M | 773.39%834.61M | 483.63%921.94M |
Transactional financial assets | --811.76M | --999.05M | --762.1M | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Notes receivable and accounts receivable | -9.40%439.86M | 2.82%884.86M | 16.99%752.73M | 35.65%763.25M | 0.55%485.52M | 55.84%860.58M | 34.23%643.41M | 61.41%562.64M | 37.56%482.87M | 37.35%552.21M |
-Notes receivable | -46.05%19.32M | -51.21%12.05M | -76.85%8.73M | -78.50%5.62M | 133.39%35.82M | -57.44%24.7M | -24.82%37.69M | -31.92%26.12M | -64.67%15.35M | 74.04%58.03M |
-Accounts receivable | -6.49%420.54M | 4.42%872.81M | 22.83%744M | 41.21%757.64M | -3.81%449.71M | 69.14%835.88M | 41.13%605.71M | 72.94%536.53M | 52.00%467.52M | 34.03%494.19M |
Other receivables (including interest and dividends) | -58.39%4.87M | -18.89%1.9M | -87.12%1.42M | -81.98%1.45M | 51.22%11.71M | -58.15%2.34M | 173.04%11M | 123.30%8.04M | 121.66%7.74M | 43.10%5.59M |
-Accrued interest receivable | ---- | ---- | ---- | ---- | ---- | ---- | --7.56M | --5.42M | --4.95M | --1.96M |
-Other receivable | ---- | ---- | ---- | -44.63%1.45M | ---- | -35.61%2.34M | ---- | -27.32%2.62M | ---- | -6.99%3.63M |
Contractual assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Advance payment | 572.38%637.1M | 90.92%30.37M | 935.61%195.88M | 11.56%15.64M | 615.38%94.75M | 192.55%15.91M | 213.78%18.91M | 469.79%14.02M | 387.04%13.25M | 99.38%5.44M |
Inventories | 17.78%1.23B | 16.80%855.77M | 9.43%1.1B | -2.54%915.67M | 15.01%1.05B | -13.41%732.68M | 3.30%1.01B | 13.38%939.5M | 2.27%909.91M | 5.51%846.11M |
Receivable financing | -42.94%9.12M | ---- | 725.35%16.21M | 905.79%3.07M | -52.35%15.98M | 133.78%2.18M | --1.96M | --304.92K | 422.17%33.55M | -98.83%931.46K |
Assets held for sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Non-current assets due within one year | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Other current assets | 2.20%153.1M | -0.77%109.03M | 9.72%132.67M | 10.73%135.73M | 63.96%149.8M | 1.76%109.88M | -14.97%120.92M | -9.77%122.58M | 9.65%91.36M | 42.48%107.97M |
Total current assets | 99.77%4.95B | 75.06%4.36B | 62.00%3.94B | 31.56%3.13B | 4.49%2.48B | 2.04%2.49B | -5.84%2.43B | 68.61%2.38B | 65.70%2.37B | 60.12%2.44B |
Non Current assets | ||||||||||
Debt investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Other debt investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Other equity investment | --4M | --4M | --4M | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Other non-current financial assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Investment real estate | -7.57%12.8M | -7.43%13.06M | -7.29%13.32M | -7.16%13.59M | -7.03%13.85M | -6.91%14.11M | -6.80%14.37M | -6.68%14.63M | -6.57%14.9M | -6.47%15.16M |
Long-term equity investment | --2.4M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Long term receivable account | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Fixed assets | ---- | ---- | ---- | 6.11%583.93M | ---- | 193.63%575.82M | ---- | 332.56%550.3M | ---- | 60.76%196.11M |
Constru in process | ---- | ---- | ---- | 1,181.31%45.24M | ---- | -83.99%42.92M | ---- | -97.52%3.53M | ---- | 3,046.96%268.14M |
Productive biological assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Oil and gas assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Intangible assets | -1.17%41.17M | 1.47%42.45M | -1.09%41.96M | 11.05%42.23M | 8.12%41.65M | 7.66%41.84M | 9.48%42.42M | -1.62%38.03M | 0.57%38.53M | 0.45%38.86M |
Development expenditure | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Long deferred expense | -67.09%2.47M | -44.46%3.17M | 40.65%9.56M | 35.27%9.33M | -2.32%7.51M | -31.18%5.72M | -14.07%6.8M | -16.21%6.9M | 36.56%7.69M | 37.90%8.31M |
Deferred tax assets | 57.22%40.69M | 43.76%36.95M | 47.50%32.15M | 48.17%28.69M | 84.90%25.88M | 50.51%25.7M | 183.60%21.79M | 213.77%19.36M | 83.71%14M | 147.63%17.08M |
Usufruct assets | -39.68%9.15M | 122.25%11.05M | 120.93%12.96M | -0.62%14.91M | -12.86%15.16M | -75.50%4.97M | -60.46%5.86M | -11.89%15M | -7.99%17.4M | -1.87%20.3M |
Other non current assets | -77.43%2.12M | -76.09%1.85M | 586.85%75.48M | -21.75%8.48M | 29.03%9.38M | -48.57%7.73M | -56.54%10.99M | -46.55%10.83M | 155.65%7.27M | 96.16%15.03M |
Total non current assets | 3.26%759.08M | 6.66%766.7M | 22.75%832.36M | 13.33%746.39M | 23.51%735.08M | 24.15%718.81M | 38.98%678.1M | 75.30%658.59M | 110.81%595.17M | 155.44%578.97M |
Total assets | 77.70%5.71B | 59.74%5.13B | 53.45%4.78B | 27.60%3.87B | 8.30%3.21B | 6.28%3.21B | 1.28%3.11B | 70.02%3.04B | 73.13%2.97B | 72.46%3.02B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | 73.02%529.3M | 844.11%765.19M | 78.09%180.13M | 18.48%188.61M | 282.18%305.93M | -32.08%81.05M | -27.56%101.14M | 203.12%159.19M | 50.22%80.05M | -8.77%119.33M |
Transactional financial liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Notes payable and accounts payable | 277.55%2.72B | 93.48%2.01B | 147.80%2.34B | 79.04%1.45B | -14.27%720.62M | 17.25%1.04B | -3.79%944.44M | 17.25%809.46M | 18.25%840.59M | 22.10%885.31M |
-Notes payable | 1,051.48%2.08B | 345.10%1.15B | 543.99%1.61B | 448.21%785.59M | -10.28%180.33M | 41.73%257.91M | 17.51%250.29M | -28.11%143.3M | 63.35%201M | -14.14%181.97M |
-Accounts payable | 19.24%644.24M | 10.31%860.56M | 4.94%728.47M | -0.38%663.66M | -15.53%540.29M | 10.92%780.17M | -9.69%694.16M | 35.66%666.16M | 8.81%639.59M | 37.06%703.34M |
Contract liabilities | -61.11%30.13M | -37.73%9.46M | -6.45%14.71M | 6.77%26.62M | 305.24%77.47M | -15.99%15.2M | -31.47%15.72M | 47.62%24.94M | -17.12%19.12M | 5.95%18.09M |
Advance receipts | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Salaries payable | 43.97%36.26M | 25.93%54.7M | 8.66%40.78M | 6.14%31.3M | -12.01%25.19M | -1.75%43.44M | 19.83%37.53M | 32.97%29.49M | 35.93%28.63M | 10.96%44.21M |
Taxs payable | 71.76%15.58M | 156.63%29.72M | 55.49%20.14M | 239.06%27.44M | 4.85%9.07M | -24.47%11.58M | -16.84%12.95M | -32.15%8.09M | -19.49%8.65M | 30.68%15.33M |
Other payable (including interest and dividends) | -71.77%18.28M | -73.91%14.93M | -53.78%26.9M | -46.46%30.22M | 11.53%64.75M | 67.78%57.24M | 441.88%58.19M | 371.63%56.45M | 630.28%58.05M | 400.79%34.11M |
-Other payable | ---- | ---- | ---- | -46.46%30.22M | ---- | 67.78%57.24M | ---- | 375.01%56.45M | ---- | 400.79%34.11M |
Hold and for sell liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Non current liabilities due within one year | -41.48%4.16M | 87.97%6.26M | 102.43%6.96M | -37.65%7.71M | -41.16%7.11M | -72.38%3.33M | -62.22%3.44M | 34.72%12.36M | 32.51%12.08M | 33.07%12.05M |
Other current liabilities | -62.19%7.07M | -23.64%9.16M | 45.73%9.67M | -9.06%6.47M | 316.84%18.71M | 56.19%11.99M | 26.61%6.64M | -30.16%7.11M | -77.64%4.49M | 18.77%7.68M |
Total current liabilities | 173.55%3.36B | 129.65%2.9B | 123.68%2.64B | 59.66%1.77B | 16.85%1.23B | 11.07%1.26B | -2.97%1.18B | 34.15%1.11B | 22.84%1.05B | 19.98%1.14B |
Current liabilities | ||||||||||
Long term loan | --40.05M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Bonds payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Long term salaries pay | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Estimate liabilities | --9.61M | --7.04M | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Deferred tax liabilities | 51.63%17.98M | 55.89%18.75M | 55.63%17.76M | 11.34%12.47M | 45.22%11.86M | -4.61%12.03M | -2.32%11.41M | 9.17%11.2M | -27.01%8.16M | 27.38%12.61M |
Long term deferred income | 7.18%8.6M | 25.13%8.98M | 25.35%9.35M | 23.01%8.3M | 14.42%8.03M | -1.57%7.17M | -1.35%7.46M | -13.91%6.74M | -13.44%7.02M | 21.51%7.29M |
Lease liabilities | -45.06%4.41M | 222.06%4.99M | 165.45%6.2M | 107.59%7.39M | 20.09%8.03M | -84.05%1.55M | -67.27%2.33M | -62.06%3.56M | -41.06%6.68M | -26.94%9.71M |
Other non current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Total non current liabilities | 188.95%80.65M | 91.58%39.76M | 57.07%33.31M | 30.94%28.15M | 27.65%27.91M | -29.91%20.75M | -19.61%21.21M | -80.01%21.5M | -49.89%21.86M | 1.44%29.61M |
Total liabilities | 173.89%3.44B | 129.03%2.94B | 122.51%2.67B | 59.12%1.8B | 17.07%1.26B | 10.03%1.28B | -3.32%1.2B | 20.99%1.13B | 19.31%1.07B | 19.43%1.17B |
Shareholders equity | ||||||||||
Paid-in capital | 0.27%250.43M | 0.79%251.13M | 0.68%250.84M | 0.72%250.94M | 0.24%249.74M | 0.89%249.16M | 0.89%249.16M | 34.52%249.16M | 34.52%249.16M | 33.34%246.97M |
Other equity instruments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
-Equity of prefer stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
-Equity of Perpetual debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Capital reserve funds | 4.52%1.27B | 4.98%1.26B | 5.35%1.25B | 6.26%1.24B | 5.30%1.21B | 6.30%1.2B | 5.42%1.18B | 405.62%1.17B | 401.90%1.15B | 393.07%1.13B |
Surplus reserve funds | 16.08%58.92M | 16.08%58.92M | 20.30%50.76M | 20.30%50.76M | 20.30%50.76M | 20.30%50.76M | 23.69%42.19M | 23.69%42.19M | 23.69%42.19M | 23.69%42.19M |
Retained profit | 24.86%582.34M | 19.12%540.22M | 9.78%505.66M | 6.21%500.01M | -1.80%466.4M | 3.25%453.52M | 7.72%460.6M | 16.89%470.79M | 29.45%474.94M | 33.91%439.24M |
Less:Treasury stock | -53.70%13.77M | -41.35%13.77M | -8.21%21.55M | -8.21%21.55M | 26.68%29.74M | --23.48M | --23.48M | --23.48M | --23.48M | ---- |
Other composite income | 618.30%457.82K | 750.16%509.97K | -125.56%-43.72K | -28.20%158.94K | 121.09%63.74K | 155.27%59.99K | -11.21%171K | 147.86%221.37K | 70.78%-302.22K | 88.56%-108.54K |
Ordinary risk reserve funds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Specific reserves | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Shareholders equity without minority interests | 10.05%2.15B | 8.65%2.09B | 6.29%2.03B | 6.01%2.02B | 2.94%1.95B | 3.92%1.93B | 4.40%1.91B | 123.66%1.91B | 132.56%1.89B | 139.28%1.85B |
Minority interests | 1,577.19%124.06M | --95.12M | --71.73M | --56.18M | --7.4M | ---- | ---- | ---- | --0 | ---- |
Total shareholder equity | 15.97%2.27B | 13.59%2.19B | 10.04%2.1B | 8.96%2.08B | 3.33%1.96B | 3.92%1.93B | 4.40%1.91B | 123.66%1.91B | 132.56%1.89B | 139.28%1.85B |
Total liabilityies and equity | 77.70%5.71B | 59.74%5.13B | 53.45%4.78B | 27.60%3.87B | 8.30%3.21B | 6.28%3.21B | 1.28%3.11B | 70.02%3.04B | 73.13%2.97B | 72.46%3.02B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.